Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Journal of Gastroenterology and Hepatology|February 26, 2013
Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantationToshihisa Matsuzaki, Ichikawa Tatsuki, Masashi Otani, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus InfectionTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Biomedical Reports|February 12, 2020
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Cancers|February 15, 2022
Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular CarcinomaRyu Sasaki, Kazuyoshi Nagata, Masanori Fukushima, et al.
Cancers|March 11, 2023
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular CarcinomaTakayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 18, 2018
Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolizationRyu Sasaki, Naota Taura, Yuri Miyazoe, et al.
Biomedical Reports|March 18, 2021
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Biomedical Reports|December 13, 2021
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamideTakuma Okamura, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 7, 2013
[A case of a patient with splenic arteriovenous fistula associated with portal hypertension who developed refractory ascites and diarrhea as initial symptom]Naoyuki Hino, Toshihisa Matsuzaki, Naohiro Komatsu, et al.
Biomedical Reports|March 26, 2019
Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/AsunaprevirTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Pageof 13